← 治験一覧に戻る
現場におけるグローバル抗凝固剤登録制度
基本情報
- NCT ID
- NCT01090362
- ステータス
- 完了
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- 57,250
- 治験依頼者名
- Thrombosis Research Institute
概要
The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a non-interventional, observational study that characterized a global population of non-valvular atrial fibrillation patients. The registry was used to document global baseline characteristics, current treatment strategies and outcome measures. Characterisation of a number of AF sub-populations was also completed. GARFIELD-AF is an independent academic research initiative sponsored by the Thrombosis Research Institute (London, UK) and supported by an unrestricted research grant from Bayer AG (Berlin, Germany).
対象疾患
Atrial Fibrillation
依頼者(Sponsor)
Quintiles(INDUSTRY)
Apothecaries Clinical Research(UNKNOWN)
University Of Birmingham(OTHER)
Brigham And Women's Hospital(OTHER)
バイエル薬品株式会社(INDUSTRY)
実施施設 (2)
独立行政法人国立病院機構大阪医療センター
Osaka, Japan
地方独立行政法人 大阪府立病院機構 大阪国際がんセンター
Osaka, Japan